Tokyo Tape
Sign in
← Santen Pharmaceutical

Quarterly report · Q3

4536.TEDINET S100SU32
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥222.8bn2023-04-01 → 2023-12-31Cons.Revenue IFRS
Revenue¥77.0bn2023-10-01 → 2023-12-31dCons.Revenue IFRS
Revenue¥279.0bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥199.8bn2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥70.9bn2022-10-01 → 2022-12-31dCons.Revenue IFRS
Operating income¥36.2bn2023-04-01 → 2023-12-31Cons.Operating profit loss IFRS
Operating income¥11.1bn2023-10-01 → 2023-12-31dCons.Operating profit loss IFRS
Operating income−¥10.1bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥8.9bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Profit before tax¥33.6bn2023-04-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax¥9.5bn2023-10-01 → 2023-12-31dCons.Profit loss before tax IFRS
Profit before tax−¥5.8bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥11.6bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥7.5bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥26.6bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥7.3bn2023-10-01 → 2023-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥14.9bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥16.1bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥6.0bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥26.6bn2023-04-01 → 2023-12-31Cons.Profit loss IFRS
Net income¥7.3bn2023-10-01 → 2023-12-31dCons.Profit loss IFRS
Net income−¥16.1bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥5.9bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Total assets¥427.8bnat 2023-12-31Cons.Assets IFRS
Total assets¥421.2bnat 2023-03-31Cons.Assets IFRS
Total assets¥420.1bnat 2022-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥129.8bnat 2023-12-31Cons.Liabilities IFRS
Total liabilities¥127.9bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥298.0bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥293.3bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥300.3bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥336.8bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥298.7bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥294.0bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥300.9bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥82.0bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥57.9bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥61.2bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥83.0bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥59.4bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥37.1bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥28.5bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥5.7bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥26.8bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥23.6bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥31.3bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥37.2bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥28.0bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥72.262023-04-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥20.722023-10-01 → 2023-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥-38.62022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-41.132022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥15.492022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥72.052023-04-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥20.662023-10-01 → 2023-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥-38.62022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-41.132022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥15.462022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio69.8%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio69.8%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.6%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 645
ItemContextValueUnit
Profit loss IFRSPrior1YTDDuration-16088000000JPY
Profit loss IFRSCurrentYTDDuration26580000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration2245000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration-577000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration6598000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration6341000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration－JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-29000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration581000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration635000000JPY
Other comprehensive income IFRSPrior1YTDDuration9424000000JPY
Other comprehensive income IFRSCurrentYTDDuration6369000000JPY
Comprehensive income IFRSPrior1YTDDuration-6664000000JPY
Comprehensive income IFRSCurrentYTDDuration32948000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration-16064000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration26613000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration-24000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration-33000000JPY
Profit loss IFRSPrior1YTDDuration-16088000000JPY
Profit loss IFRSCurrentYTDDuration26580000000JPY
Comprehensive income attributable to owners of parent IFRSPrior1YTDDuration-6646000000JPY
Comprehensive income attributable to owners of parent IFRSCurrentYTDDuration33002000000JPY
Comprehensive income attributable to non controlling interests IFRSPrior1YTDDuration-18000000JPY
Comprehensive income attributable to non controlling interests IFRSCurrentYTDDuration-53000000JPY
Comprehensive income IFRSPrior1YTDDuration-6664000000JPY
Comprehensive income IFRSCurrentYTDDuration32948000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration-41.13
Basic earnings loss per share IFRSCurrentYTDDuration72.26
Diluted earnings loss per share IFRSPrior1YTDDuration-41.13
Diluted earnings loss per share IFRSCurrentYTDDuration72.05
Revenue IFRSPrior1QuarterDuration70871000000JPY
Revenue IFRSCurrentQuarterDuration77027000000JPY
Cost of sales IFRSPrior1QuarterDuration29548000000JPY
Cost of sales IFRSCurrentQuarterDuration32145000000JPY
Gross profit IFRSPrior1QuarterDuration41323000000JPY
Gross profit IFRSCurrentQuarterDuration44881000000JPY
Selling general and administrative expenses IFRSPrior1QuarterDuration23206000000JPY
Selling general and administrative expenses IFRSCurrentQuarterDuration21575000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1QuarterDuration7415000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentQuarterDuration5747000000JPY
Amortization on intangible assets associated with products IFRSPrior1QuarterDuration2059000000JPY
Amortization on intangible assets associated with products IFRSCurrentQuarterDuration2383000000JPY
Other income IFRSPrior1QuarterDuration262000000JPY
Other income IFRSCurrentQuarterDuration155000000JPY
Other expenses IFRSPrior1QuarterDuration32000000JPY
Other expenses IFRSCurrentQuarterDuration4273000000JPY
Operating profit loss IFRSPrior1QuarterDuration8874000000JPY
Operating profit loss IFRSCurrentQuarterDuration11058000000JPY
Finance income IFRSPrior1QuarterDuration428000000JPY
Finance income IFRSCurrentQuarterDuration486000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2023-10-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass